Medicxi IV LP - 27 Dec 2024 SCHEDULE 13G Report for RAPT Therapeutics, Inc. Common Stock, $0.0001 par value (RAPT)

Filing Manager
Medicxi IV LP
Reporting Manager
Medicxi IV GP Limited
Security
RAPT Therapeutics, Inc. Common Stock, $0.0001 par value
Symbol
RAPT
Shares outstanding
132,260,355 shares
Disclosed Ownership
22,352,000 shares
Ownership
16.9%
Form type
SCHEDULE 13G
Filing time
06 Jan 2025, 09:22:02 UTC
Date of event
27 Dec 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Medicxi IV LP 16.6% 21,977,977 21,977,977 0 /s/ Giles Johnstone-Scott Giles Johnstone-Scott, Director of Manager
Medicxi Co-Invest IV LP 0.3% 374,023 374,023 0 /s/ Giles Johnstone-Scott Giles Johnstone-Scott, Director of Manager
Medicxi IV GP Limited 16.9% 22,352,000 22,352,000 0 /s/ Nigel Crocker Nigel Crocker, Alternate Director
Medicxi Ventures Management (Jersey) Limited 16.9% 22,352,000 22,352,000 0 /s/ Giles Johnstone-Scott Giles Johnstone-Scott, Director